興科蓉醫藥：2019中期報告.pdf

1、INTERIM REPORT中期報告2019(Incorporated under the laws of the Cayman Islands with limited liability)(根據開曼群島法例註冊成立的有限公司)Stock Code 股份代號:6833(Incorporated under the laws of the Cayman Islands with limited liability)(根據開曼群島法例註冊成立的有限公司)Stock Code 股份代號:6833Contents目錄2Corporate Information公司資料4Financial Highl

2、ights財務摘要6Corporate Profile公司簡介7Management Discussion and Analysis管理層討論及分析26Other Information其他資料38Report on Review of Interim Condensed Financial Information中期簡明財務資料審閱報告40Interim Consolidated Statement of Profit or Loss and Other Comprehensive Income中期綜合損益及其他全面收益表41Interim Consolidated Statement of

3、 Financial Position中期綜合財務狀況表43Interim Consolidated Statement of Changes in Equity中期綜合權益變動表44Interim Consolidated Statement of Cash Flows中期綜合現金流量表47Notes to Interim Condensed Financial Information中期簡明財務資料附註82Definitions釋義2Sinco Pharmaceuticals Holdings Limited Interim Report 2019Corporate Information

4、公司資料BOARD OF DIRECTORSExecutive DirectorsMr.Huang Xiangbin(Chairman and Chief Executive Officer)Ms.Zhang ZhijieIndependent Non-executive DirectorsMr.Lau Ying KitMr.Wang QingMr.Liu WenfangAUDIT COMMITTEEMr.Lau Ying Kit(Chairman)Mr.Liu WenfangMr.Wang QingREMUNERATION COMMITTEEMr.Wang Qing(Chairman)Ms.

5、Zhang ZhijieMr.Liu WenfangNOMINATION COMMITTEEMr.Huang Xiangbin(Chairman)Mr.Liu WenfangMr.Lau Ying KitINTERNAL CONTROL AND CORPORATE GOVERNANCE COMMITTEEMr.Lau Ying Kit(Chairman)Mr.Wang QingMr.Liu WenfangAUTHORISED REPRESENTATIVESMr.Huang XiangbinMs.Ko Wing Yu(appointed on 29 March 2019)Ms.Leung Sue

6、t Lun(resigned on 29 March 2019)COMPANY SECRETARYMs.Ko Wing YuMs.Leung Suet Lun(resigned on 29 March 2019)REGISTERED OFFICEPO Box 309Ugland HouseGrand Cayman,KY1-1104Cayman Islands董事會執行董事黃祥彬先生（主席兼行政總裁）張志傑女士獨立非執行董事劉英傑先生汪晴先生劉文芳先生審核委員會劉英傑先生（主席）劉文芳先生汪晴先生薪酬委員會汪晴先生（主席）張志傑女士劉文芳先生提名委員會黃祥彬先生（主席）劉文芳先生劉英傑先生內部控